Arthroscopic Surgery vs Non-Operative Treatment for Tennis Elbow
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if arthroscopic surgery, a minimally invasive procedure using small incisions and a camera, effectively treats chronic tennis elbow compared to non-surgical methods. Researchers will divide participants into two groups: one will receive the surgical procedure, and the other will not undergo surgery. The study targets individuals who have experienced tennis elbow symptoms for over six months without relief from other treatments. As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance treatment options for chronic tennis elbow.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that arthroscopic tennis elbow release is safe?
Research has shown that arthroscopic surgery for tennis elbow is generally safe. Studies have found that 91% to 97.7% of patients experience improvement after this procedure.
Both arthroscopic and open surgeries for tennis elbow have similar safety profiles and risks, indicating that the arthroscopic method is as safe as traditional open surgery. The success rate is also high; one study reported a 92% success rate for the arthroscopic approach. Although all surgeries carry some risks, these figures suggest that this procedure is well-tolerated by patients.12345Why are researchers excited about this trial's treatments?
Most treatments for tennis elbow focus on rest, physical therapy, or injections to manage pain and inflammation. However, the arthroscopic tennis elbow release is unique because it involves a minimally invasive surgical technique that directly addresses the affected tendons through a two-portal approach. Researchers are excited about this method because it has the potential to provide faster and more effective relief by precisely targeting and releasing the damaged tissue, potentially leading to quicker recovery times compared to traditional non-operative treatments.
What evidence suggests that this trial's treatments could be effective for tennis elbow?
This trial will compare arthroscopic surgery for tennis elbow with non-operative treatment. Research has shown that arthroscopic surgery yields promising results. In past studies, 91% to 97.7% of patients improved after the procedure, indicating that many people feel much better and can use their arm more easily afterward. Some studies also mention that the duration of symptoms before surgery might not affect its effectiveness. Overall, these findings strongly suggest that arthroscopic surgery can effectively treat long-lasting tennis elbow.13678
Who Is on the Research Team?
J W Pollock, MD
Principal Investigator
The Ottawa Hospital
Are You a Good Fit for This Trial?
This trial is for individuals who have been experiencing tennis elbow symptoms for at least 9 months and haven't improved with standard treatments. It's not suitable for those with workers' compensation claims, previous severe elbow injuries or surgeries, or other conditions that better explain their symptoms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either arthroscopic tennis elbow release or non-operative management
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Arthroscopic tennis elbow release
- Non operative
Arthroscopic tennis elbow release is already approved in European Union, United States, Canada for the following indications:
- Chronic lateral epicondylitis
- Tennis elbow
- Chronic lateral epicondylitis
- Tennis elbow
- Chronic lateral epicondylitis
- Tennis elbow
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Hospital Research Institute
Lead Sponsor